SEC Company Response from RadNet, Inc. (RDNT) (CIK 0000790526) (RDNT) — Oct 16, 2006
RadNet, Inc. (RDNT) (CIK 0000790526)
Date: Oct. 16, 2006 · CIK: 0000790526 · Accession: 0001104659-06-066868
AI Filing Summary & Sentiment
File numbers found in text: 333-136800
Letter
Primedex Health Systems, Inc.
1510 Cotner Avenue
Los Angeles, CA 90025
October 16, 2006
Via EDGAR Transmission and Overnight Mail
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E., Mail Stop 3561
Washington, D.C. 20549-0404
Attention: John Reynolds,
Assistant Director
RE: Primedex Health Systems, Inc.
Registration Statement on Form S-4 (File No. 333-136800)
Acceleration Request
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Primedex Health Systems, Inc. (the “Company”) hereby requests the Securities and Exchange Commission (the “Commission”) to accelerate the effective date of the above-referenced Registration Statement and declare the Registration Statement, as then amended, effective as of 9:00 a.m., California time, on Tuesday, October 17, 2006, or as soon thereafter as practicable. The Company also requests that the Commission specifically confirm such effective date and time to the Company in writing. The Company further requests that we be notified of such effectiveness by telephone call to Linda Michaelson of Sheppard, Mullin, Richter & Hampton LLP at (310) 228-3711.
The Company acknowledges that:
· should the Commission or the Staff of the Commission (the “Staff”) acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Registration Statement;
· the action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and
Securities and Exchange Commission
October 16, 2006
· the Company may not assert this action as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Sincerely,
PRIMEDEX HEALTH SYSTEMS, INC.
Show Raw Text
CORRESP 1 filename1.htm Primedex Health Systems, Inc. 1510 Cotner Avenue Los Angeles, CA 90025 October 16, 2006 Via EDGAR Transmission and Overnight Mail Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E., Mail Stop 3561 Washington, D.C. 20549-0404 Attention: John Reynolds, Assistant Director RE: Primedex Health Systems, Inc. Registration Statement on Form S-4 (File No. 333-136800) Acceleration Request Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Primedex Health Systems, Inc. (the “Company”) hereby requests the Securities and Exchange Commission (the “Commission”) to accelerate the effective date of the above-referenced Registration Statement and declare the Registration Statement, as then amended, effective as of 9:00 a.m., California time, on Tuesday, October 17, 2006, or as soon thereafter as practicable. The Company also requests that the Commission specifically confirm such effective date and time to the Company in writing. The Company further requests that we be notified of such effectiveness by telephone call to Linda Michaelson of Sheppard, Mullin, Richter & Hampton LLP at (310) 228-3711. The Company acknowledges that: · should the Commission or the Staff of the Commission (the “Staff”) acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Registration Statement; · the action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and Securities and Exchange Commission October 16, 2006 · the Company may not assert this action as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. Sincerely, PRIMEDEX HEALTH SYSTEMS, INC. By: /s/ Dr. Howard G. Berger, M.D. Dr. Howard G. Berger, M.D. President and Chief Executive Officer cc: Linda Michaelson 2